CD95 (APO-1/Fas)-associating signalling proteins

Cell Death and Differentiation

Volumn 3, Issue 2, 1996, Pages 161-170

  Peter, Marcus E ^a   Kischkel, Frank C ^a   Hellbardt, Stefan ^a   Chinnaiyan, Arul M ^b   Krammer, Peter H ^a   Dixit, Vishva M ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CAP proteins; CD95 (APO 1 Fas); DISC; Signal transduction; TNF R family

Indexed keywords

FAS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; NERVE GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CELL DEATH; HUMAN; LIGAND BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029933918     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. Bazzoni F, Alejos E and Beutler B (1995) Chimeric tumor necrosis factor receptors with constitutive signaling activity. Proc. Natl. Acad. Sci. USA 92: 5376-5380
2. Beidler DR, Tewari M, Friesen PD, Poirier G and Dixit VM (1995) The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270: 16526-16528
3. Belka C, Wiegmann K, Adam D, Holland R, Neuloh M, Herrmann F, Kränke M and Brach MA (1995) Tumor necrosis factor (TNF)-a activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase, EMBO J. 14: 1156-1165
4. L. Immunity 3: 87-98
5. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH and Wallach D (1995a) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795-7798
6. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, Camonis JH and Wallach D (1995b) Self-association of the 'death domains' of the p55 Tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/ APO1 effects. J. Biol. Chem. 270: 387-391
7. Brakebusch C, Nophar Y, Kemper O, Engelmann H and Wallach D (1992) Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signaling, but not induced shedding of the receptor. EMBO J. 11: 943-950
8. Branellec D, De Cremoux P, Barreau P, Calvo F and Chouaib S (1992) Tumor necrosis factor-mediated cell lysis in vitro: re411715lationship to cAMP accumulation and guanine nucleotide-binding proteins. Eur. J. Immunol. 22: 963-967
9. Briscoe J, Guschin D and Muller M (1994) Signal transduction. Just another signalling. Curr. Biol. 4: 1033-1035
10. Cahill M, Peter ME, Kischkel FC, Hellbardt S, Chinnaiyan A, Dixit VM, Krammer PH and Nordheim A (1996) CD95 (APO-1/Fas) induces activation of Jun and histone kinases, submitted
11. Cheng G, Cleary AM, Ye ZS, Hong DI, Lederman S and Baltimore D (1995) Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267: 1494-1498
12. Chinnaiyan AM, O'Rourke K, Tewari M and Dixit VM (1995) FADD, a novel death domain-containing protein interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512
13. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Lou L, Kischkel FC, Hellbardt S, Krammer PH, Peter ME and Dixit VM (1996) FADD/MORT1 is a common mediator of Fas/APO-1- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271: 4961-4965
14. Chu K, Niu X and Willams LT (1995) A novel protein. FAF1, potentiates Fas-mediated apoptosis. Proc. Natl. Acad. Sci. USA In press
15. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A and Testi R (1994) Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 177: 1547-1552
16. Copeland KF, Haaksma AG, Goudsmit J, Krammer PH and Heeney, JL (1994) Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res. Hum. Retroviruses. 10: 1259-1268
17. Darnay BG, Reddy SA and Aggarwal BB (1994a) Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor. J. Biol. Chem. 269: 20299-20304
18. Darnay BG, Reddy SA and Aggarwal BB (1994b) Physical and functional association of a serine-threonine protein kinase to the cytoplasmic domain of the p80 form of the human tumor necrosis receptor in human histiocytic lymphoma U-937. J. Biol. Chem. 269: 19687-19690
19. Darnay BG, Singh S, Chaturvedi MM and Aggarwal BB (1995) The p60 tumor necrosis factor (TNF) receptor-associated kinase (TRAK) binds residues 344-397 within the cytoplasmic domain involved in TNF signaling. J. Biol. Chem. 270: 14867-14870
20. Darnell JE Jr, Kerr IM and Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1412
21. Debatin K-M, Goldmann CK, Bamford R, Waldmann TA und Krammer PH (1990) Monoclonal antibody mediated apoptosis in adult T cell leukemia. Lancet 335: 497-500
22. Deiss LP, Feinstein E, Berissi H, Cohen O and Kimchi A (1995) Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the g interferon-induced cell death. Genes Dev. 9: 15-30
23. Dhein J, Daniel PT, Trauth BC, Oehm A, Möller P and Krammer PH (1992) Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149: 3166-3176
24. Eischen CM, Dick CJ, and Leibson PJ (1994) Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153: 1947-1954
25. Enari M, Hug H and Nagata S (1995a) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-81
26. Enari M, Hase A and Nagata S (1995b) Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 14: 5201-5208
27. Engel K, Ahlers A, Brach MA, Herrmann F and Gaestel M (1995) MAPKAP kinase 2 is activated by heat shock and TNF-alpha. In vivo phosphorylation of small heat shock protein results from stimulation of the MAP kinase cascade. J. Cell. Biol. 57: 321-330
28. Feinstein E, Kimchi A, Wallach D, Boldin M and Varfolomeev E (1995) The death domain: a module shared by proteins with diverse cellular functions. TIBS 20: 342-344
29. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ and Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81, 935-946
30. Golstein P, Marguet D and Depraetere V (1995) Homology between reaper and the cell death domains of Fas and TNFRI. Cell 81: 185-186
31. Grell M, Krammer PH and Scheurich P (1994) Segregation of APO-1/Fas and TNF receptor-mediated apoptosis. Eur. J. Immunol. 24: 2563-2566
32. Gulbins E, Bissonette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A and Green D (1995) FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2: 341-351
33. Guy GR, Cao X, Chua SP and Tan YH (1992) Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J. Biol. Chem. 267: 1846-1852
34. Hashimoto S, Ishii A and Yonehara S (1991) The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas. Int. Immunol. 3: 343-351
35. Heldin C-H (1995) Dimerization of cell surface receptors in signal transaction. Cell 80: 213-223
36. Hofmann K and Tschopp J (1995) The death domain motif in Fas(Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance. FEBS Lett. 371: 321-323
37. Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation. Cell 81: 495-504
38. Hu HM, O'Rouke K, Boguski, MS and Dixit VM (1994) A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269: 30069-30072
39. Hug H, Enari M and Nagata S (1994) No requirement of reactive oxygen intermediates in Fas-mediated apoptosis. FEBS Lett. 351: 311-313
40. Ihle JN and Kerr IM (1995) Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11: 69-74
41. Imamura K, Sherman ML, Spriggs D and Kufe D (1988) Effect of tumor necrosis factor on GTP binding and GTPase activity in HL-60 and L929 cells. J. Biol. Chem. 263: 10247-10253
42. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y and Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243
43. Itoh N and Nagata S (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268: 10932-10937
44. Itoh N, Tsujimoto Y and Nagata S (1993) Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151: 621-627
45. Janssen O, Lengl-Janßen B, Oberg H-H, Robertson MJ and Kabelitz D (1995) Induction of cell death via Fas (CD95/APO-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation, Immunol. Lett., in press
46. Jaattela M, Benedict M, Tewari M, Shayman JA and Dixit VM (1995) Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10: 2297-2305
47. Klas C, Debatin K-M, Jonker RR and Krammer PH (1993) Activation interferes with the APO-1 pathway in mature human T cells. Internatl. Immunol. 5: 625-630
48. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH and Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-Inducing signalling complex (DISC) with the receptor EMBO J. 14: 5579-5588
49. r. Biochem. J. 267: 91-98
50. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Bäumler C, Hellbardt S, Germer M, Peter ME and Debatin K-M (1994) The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142: 175-191
51. Lagresle C, Bella C, Daniel P, Krammer PH and Defrance T (1995) Regulation of germinal center B cell differentiation: Role of the human APO-1/Fas (CD95) molecule. J. Immunol. 154: 5746-5756
52. Lahti JM, Xiang J, Heath LS, Campana D and Kidd VJ (1995) PITSLRE protein kinase activity is associated with apoptosis. Mol. Cell. Biol. 15: 1-11
53. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH und Möller P (1993) Constitutive and induced expression of APO-1, a new member of the NGF/TNF receptor superfamily, in normal and neoplastic cells. Lab Invest. 69: 415-429
54. Los M, van de Craen M, Penning L, Schenk H, Westendorp M, Bäuerle P, Dröge W, Krammer PH, Fiers W and Schulze-Osthoff K (1995) Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375: 81-83
55. Maekawa K, Imagawa N, Nagamatsu M and Harada S (1994) Molecular cloning of a novel protein tyrosine-binding domain and GLGF repeats. FEBS Lett. 337: 200-206
56. Mariani SM, Matiba B, Armandola EA and Krammer PH (1994) The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol. 24: 3119-3123
57. Marino MW, Pfeffer LM, Guidon PT Jr and Donner DB (1989) Tumor necrosis factor induces phosphorylation of a 28 kDa mRNA cap-binding protein in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 86: 8417-8421
58. Martin SJ, Newmeyer DD, Mathias S, Farschon DM, Wang H-G, Reed JC, Kolesnick RN and Green DR (1995) Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J. 14: 5191-5200
59. Möller P, Koretz K, Leithauser F, Brüderlein S, Henne C, Quentmeier A and Krammer PH (1994) Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer. 57: 371-377
60. Memon SD, Guy GR and Tan YH (1995) Involvement of a putative protein-tyrosine phosphatase and I kappa B-alpha serine phosphorylation in nuclear factor kappa B activation by tumor necrosis factor. J. Biol. Chem. 270: 18881-18887
61. Mosialos G, Birkenbach M, Yalamanchili R, VanArdale T, Ware C and Kieff E (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80: 389-399
62. Naismith JH, Devine TQ, Branhuber BJ and Sprang, SR (1995) Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor, J. Biol. Chem. 270: 13303-13307
63. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J and Nagata S (1994) Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell. Res. 215: 332-337
64. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M Lazebnik, YA Munday, NA Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43
65. Oberg H-H, Robertson MJ, Kabelitz D and Janssen O (1996) Differential role of tyrosine phosphorylation in the induction of cell death via Fas (CD95/APO-1) and the T cell receptor/CD3 complex, submitted
66. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H and Krammer PH (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/ nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267: 10709-10715
67. 2+ level. J. Immunol. 154: 599-609
68. Oyaizu N, Than S, McCloskey TW and Pahwa S (1995) Requirement of p56(lck) in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction Jurkat cells. Bioch. Bioph. Res. Com. 213: 994-1001
69. Peter ME, Hellbardt S, Schwartz-Albiez R, Westendorp MO, Walczak H, Moldenhauer G, Grell M and Krammer PH (1995) Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cells death. Cell Death Diff. 2: 163-171
70. Pun KT, Farrow SN, Raven T, Wride CJ, White JHM and Brown R (1996) Adenovirus E1B-19K interacts with a novel apoptotic inducer, nbk. J. Biol. Chem.: submitted
71. Rafiee P, Lee JK, Leung CC and Raffin, TA (1995) TNF-α induces tyrosine phosphorylation of mitogen-activated protein kinase in adherent human neutrophils. J. Immunol. 154: 4785-4792
72. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin K-M, Fischer A and de Villartay JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349
73. Rothe M, Wong SC, Henzel WJ and Goeddel DV (1994) A novel family of putative signal transducers associated with the cytoplasmic domain if the 75 kDa tumor necrosis factor receptor. Cell 78: 681-692
74. Rothe M, Sarma V, Dixit M and Goeddel DV (1995) TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269: 1424-1427
75. Saleem A, Yuan ZM, Taneja N, Rubin E, Kufe DW and Kharbanda SM (1995) Activation of serine/threonine protein kinase and early growth response 1 gene expression by tumor necrosis factor in human myeloid leukemia cells. J. Immunol. 154: 4150-4156
76. Sato T, Irie S, Kitada S and Reed JC (1995a) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268: 411-413
77. Sato T, Irie S and Reed JC (1995b) A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358: 113-118
78. Schraven B and Peter ME (1995) APO-1 (CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett. 368: 491-494
79. Schreck RP, Rieber P and Bäuerle PA (1991) Reactive oxygen intermediates as apparently widely used messenger in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10: 2247-2258
80. Schütze P, Scheurich P, Pfizenmaier K and Krönke M (1989) Tumor necrosis factor signaling. J. Biol. Chem. 264: 3562-3567
81. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA and Fiers W (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267: 5317-5323
82. Schulze-Osthoff K, Krammer PH and Dröge W (1994) Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13: 4587-4596
83. Seufert W, Futcher B and Jentsch S (1995) Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373: 78-81
84. Singer GG, Carrera AC, Marshak-Rothstein A, Martinez C and Abbas AK (1994) Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr. Opin. Immunol. 6: 913-920
85. Smith CA, Farrah T and Goodwin RG (1994) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Cell 76: 959-962
86. Song HY, Dunbar JD and Donner DB (1994) Aggregation of the intracellular domain of the type I tumor necrosis factor receptor defined by the two-hybrid system. J. Biol. Chem. 269: 22492-22495
87. Song HY and Donner DB (1995) Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor. Biochem. J. 309: 825-829
88. Song HY, Dunbar JD, Zhang YX, Guo D and Donner DB (1995) Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J. Biol. Chem. 270: 3574-3581
89. Stanger BZ, Leder P, Lee T-H, Kim E and Seed B (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in Yeast and causes cell death. Cell 81: 513-523
90. Strasser A, Harris AW, Krammer PH and Cory S (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis, EMBO J., In press
91. Su X, Zhou T, Wang Z, Yang P, Jope RS and Mountz J (1995) Defective expression of hemapoetic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2: 353-362
92. Suda T, Nagata S (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179: 873-879
93. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr and Goeddel DV (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88: 9292-9296
94. Tartaglia LA and Goeddel DV (1992) Tumor necrosis receptor signaling. J. Biol. Chem. 267: 4304-4307
95. Tartaglia LA, Ayres TM, Wong GHW and Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845-853
96. Taupin J-L, Tian Q, Kedersha N, Robertson M and Anderson P (1995) The RNA binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc. Natl. Acad. Sci. USA 92: 1629-1633
97. Tepper C, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S, Hannun YA and Seldin MF (1995) Role of ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92: 8443-8447
98. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zheng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM (1995a) Yama/CPP32b, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 1-20
99. Tewari M, Beidler DR and Dixit VM (1995b) CrmA-inhibitable cleavage of the 70-RDa protein component of the U1 small nuclear ribonucleoprotein during Fas- and TNF-induced apoptosis. J. Biol. Chem. 270: 18738-18741
100. Tewari M and Dixit VM (1995) Fas- and Tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270: 3255-3260
101. Tian Q, Taupin J-L, Elledge S, Robertson M and Anderson P (1995) Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp.Med. 182: 865-874
102. Vandenabeele P, Declercq W, Beyaert R and Fiers W (1995) Two tumour necrosis factor receptors: structure and function. TIBS 5: 392-399
103. VanArsdale TL and Ware CF (1994) TNF receptor signal transduction. J. Immunol. 153: 3043-3050
104. van der Geer P, Hunter T and Lindberg R A (1994) Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell. Biol. 10: 251-337
105. Vietor I, Schwenger P, Li W, Schlessinger J and Vilcek J (1993) Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J. Biol. Chem. 268: 18994-18999
106. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S and Golstein P (1995) TCR CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181: 781-786
107. Watanabe-Fukunaga R, Brannan Cl, Copeland NG, Jenkins NA and Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317
108. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y und Fontana A (1994) Anti-Fas/APO-1 antibody mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94: 954-964
109. White K, Grether ME, Abrams JM, Young L, Farrell K and Steller H (1994) Genetic control of programmed cell death in Drosophila. Science 264: 677-683
110. Westwick JK, Weitzel C, Minden A, Karin M and Brenner DA (1994) Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269: 26396-26401
111. Wong GHW and Goeddel DV (1994) Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152: 1751-1755
112. Wright DA and Geha RS (1996) Association of human Fas (CD95) with a novel ubiquitin conjugating enzyme. Submitted for publication
113. Yanaga F, Abe M, Koga T and Hirata M (1992) Signal transduction by tumor necrosis factor α is mediated through a guanine nucleotide-binding protein in osteoblast-like cell line MC3T3-E1. J. Biol. Chem. 267: 5114-5121